Multiomics

Multiomics

  • Home
  • About project
  • Project Structure
  • News
  • Publications
  • Contacts

Recent Advances in Understanding the Pathophysiology of Fabry Disease

by admin | Jun 30, 2025 | News | 0 comments

Fabry disease is an inherited metabolic disease that is caused by an abnormal accumulation of sphingolipids, including globotriaosylceramide (Gb-3), in lysosomes. Patients with Fabry disease have reduced or absence of an enzyme called α-galactosidase, which catabolizes…

Source: https://karger.com/nef/article/doi/10.1159/000546085/929634/Recent-Advances-in-Understanding-the

Submit a Comment Cancel reply

You must be logged in to post a comment.

Recent Posts

  • Single-Molecule Real-Time Sequencing for MUC1 Variable Number of Tandem Repeat Variation to Improve Autosomal Dominant Tubulointerstitial Kidney Disease Diagnosis
  • Recurrent Single-Nucleotide Insertions in the Mitochondrial Second Light-Strand Promoter Cause Tubulointerstitial Kidney Disease
  • A role for EHMT2 in a novel autosomal recessive neurodevelopmental syndrome? A case report
  • paRDal: Bioinformatics Framework for a Parallel RNA and DNA NGS Analysis in Hereditary Cancer Diagnostics
  • Tri‐Parametric Assessment of α‐Galactosidase A Activity, lysoGb3 and X‐Inactivation Aids Genotype‐Phenotype Categorization of Fabry Disease Female Patients

Recent Comments

No comments to show.

The MULTIOMICS_CZ project is supported by programme Johannes Amos Comenius, Ministry of Education, Youth and Sports of the Czech Republic,
ID Project CZ.02.01.01/00/23_020/0008540 – Co-funded by the European Union.

Multiomics © 2025

Website created by CyberCats 🐈